A study by Fang et al. (2005[48]) demonstrated that apigenin attenuates angiogenesis and tumor growth by enhancing p53 activity through AKT-mediated phosphorylation of its negative regulator HDM2 in ovarian cancer cells (Fang et al., 2005[48]). The gene discussed is TP53; the disease is neoplasm.